Open Access

ARTICLE

Piperlongumine in combination with EGFR tyrosine kinase inhibitors for the treatment of lung cancer cells

SHAIL RAKESH MODI, TERRICK ANDEY^*

Department of Pharmaceutical Sciences, Massachusetts College of Pharmacy and Health Sciences, Worcester, MA 01608, USA

* Corresponding Author: TERRICK ANDEY. Email: